Stock Events

Alcon 

CHF80.2
+CHF0.62+0.78% Friday 16:31

Statistics

Day High
80.6
Day Low
79.68
52W High
85.34
52W Low
61.28
Volume
650,849
Avg. Volume
590,737
Mkt Cap
40.43B
P/E Ratio
42.69
Dividend Yield
0.29%
Dividend
0.23

Upcoming

Dividends

0.29%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
34%
1Y Growth
12.08%

Earnings

12NovExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
0
0.26
0.52
0.78
Expected EPS
0.74659714752
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALC.SW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Show more...
CEO
Mr. F. Michael Ball
Employees
25000
Country
CH
ISIN
CH0432492467

Listings